Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin

Clinical Trial Summary

The primary objective was to evaluate the effect of 12 weeks of subcutaneous evolocumab (AMG 145), compared with ezetimibe, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia unable to tolerate an effective dose of a statin.

See also
Status	Clinical Trial	Phase
Completed	`NCT00001154` - Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Completed	`NCT02927184` - Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease	Phase 2
Completed	`NCT04640012` - Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects	Phase 1
Completed	`NCT03213288` - Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status	N/A
Completed	`NCT00382564` - Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease	N/A
Recruiting	`NCT02979704` - A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia	Phase 2/Phase 3
Completed	`NCT02569814` - A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin	Phase 1
Completed	`NCT02280590` - Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia	Phase 4
Completed	`NCT02428998` - Safety for 24 Weeks Intake of Korean Red Ginseng in Adults	N/A
Completed	`NCT01678183` - Financial Incentives for Medication Adherence	N/A
Completed	`NCT01694446` - Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose	N/A
Completed	`NCT01426412` - A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol	Phase 1
Completed	`NCT01131832` - Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols	Phase 4
Completed	`NCT00534105` - Lipid Metabolism in Gestational Diabetes	N/A
Completed	`NCT00758303` - A Study to Evaluate the Lipid Regulating Effects of TRIA-662	Phase 2/Phase 3
Recruiting	`NCT00408824` - Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)	N/A
Completed	`NCT00362206` - Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin	Phase 3
Terminated	`NCT00299169` - Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes	Phase 4
Completed	`NCT00701454` - Survey of Thai-Muslim Health Status	N/A
Completed	`NCT00381992` - Risk Assessment of Long-Haul Truck Drivers	N/A

NCT number	NCT01375764
Study type	Interventional
Source	Amgen
Contact
Status	Completed
Phase	Phase 2
Start date	July 28, 2011
Completion date	May 8, 2012

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects — GAUSS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms